Alprostadil Injection (PROSTAGLANDIN E1)
Alprostadil Injection is a new cardiovascular agent, improve cardiovascular and cerebrovascular microcirculation treat peripheral vascular disease and ulcer induced by chronic arterial occlusive disease. For the treatment of Chronic arterial occlusion, progressive systemic sclerosis, systemic lupus erythematosus, diabetes mellitus, vibration disease.
Alprostadil can dilate peripheral blood vessels and increases blood flow, and thereby improves ulcers of limbs and pains.
2ml:10μg and 1ml:5μg
Free fatty acid
Not more than the volume of 0.01mol/L NaOH TS consumed by the reference solution
Not more than 0.2ml of Na2S2O3 TS consumed
The average globule size ranges from 120nm~280nm. The diameter of 90% droplet is less than 350nm.
Not more than 3.0%
Not more than 3.0mcg per ml
10mcg of particles＜50, 25mcg of particles ＜5
Less than 2.5EU/ml